SCHEMBL18506964

SCHEMBL18506964

CCOC(=O)c1c(N(C)C)sc2c1CCCC2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.66
MAPT P10636 6/20 0.66
ALDH1A1 P00352 6/20 0.66
GAA P10253 3/20 0.66
ALOX15 P16050 2/20 0.66
HSD17B10 Q99714 2/20 0.66
HPGD P15428 2/20 0.66
MAPK1 P28482 1/20 0.66
ADRA2A P08913 2/20 0.57
ADRA2B P18089 2/20 0.57
ADRA2C P18825 2/20 0.57
TSHR P16473 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
LMNA P02545 1/20 0.53
ATM Q13315 1/20 0.53
CNR1 P21554 1/20 0.52
CNR2 P34972 1/20 0.52
KMT2A Q03164 1/20 0.52
TLR2 O60603 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10241785 0.83 MAPT (0.75) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL10660775 0.80 MAPT (0.58) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL19475084 0.80 MAPT (0.55) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL133642 0.79 MAPT (1.00) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL19879527 0.79 MAPT (0.69) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL6999008 0.79 ALDH1A1 (0.69) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL19141297 0.79 MAPT (0.69) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL11367913 0.79 MAPT (0.57) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL4090734 0.78 ALDH1A1 (0.97) KDM4EMAPTALDH1A1GAAALOX15
SCHEMBL1887318 0.78 ALDH1A1 (0.97) KDM4EMAPTALDH1A1GAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809602-B2 Compounds for treating viral infections INSTITUT PASTEUR KOREA (KR) 2017-11-07 US disclosed
US-20170044181-A1 COMPOUNDS FOR TREATING VIRAL INFECTIONS INSTITUT PASTEUR KOREA (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044181-A1 COMPOUNDS FOR TREATING VIRAL INFECTIONS HAVCR2, MAVS, EIF2AK2 KDM4E 4004/4885MAPT 2197/4885ALDH1A1 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.